The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Daratumumab + bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA.
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Celgene; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Novartis
Research Funding - Abbvie (Inst)
 
Philippe Moreau
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Takeda
 
Aurore Perrot
Honoraria - Amgen; Celgene; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Sanofi; Takeda
 
Cyrille Hulin
Honoraria - Amgen; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen
 
Mamoun Dib
No Relationships to Disclose
 
Mourad Tiab
No Relationships to Disclose
 
Denis Caillot
No Relationships to Disclose
 
Thierry Facon
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Speakers' Bureau - celgene; Janssen; Takeda
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Oncopeptides; Pierre Fabre; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Novartis; SERVIER; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis
 
Annemiek Broijl
Honoraria - Amgen; Celgene; Takeda
Consulting or Advisory Role - Amgen; Celgene; Takeda
 
Sonja Zweegman
Consulting or Advisory Role - Celgene; Janssen; Sanofi; Takeda
Research Funding - Janssen; Takeda
 
Mark-David Levin
Honoraria - Abbvie; Amgen; Celgene; Janssen
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Janssen
 
Michel Delforge
Honoraria - Amgen; Celgene; Janssen
Speakers' Bureau - Celgene (Inst); Janssen (Inst)
Research Funding - Celgene; Janssen
 
Lixia Pei
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Veronique Vanquickelberghe
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Carla De Boer
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Tobias Kampfenkel
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Jessica Vermeulen
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Pieter Sonneveld
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Skyline Diagnostics; Takeda